mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.052 |
0.4 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |